Exhibit List. Exhibit A Licensed Know-How & Licensed Materials Exhibit B Licensed Patents Exhibit C Permitted CMOs/CROs Exhibit D Licensed Compounds Exhibit E Supplemental Confidentiality Agreement Exhibit F Reservation Agreement Exhibit G Ongoing Studies Exhibit H [***] Order Summary This EXCLUSIVE LICENSE AGREEMENT (this “Agreement”) is entered into as of July 9, 2020 (the “Effective Date”) by and between AMGEN INC., a Delaware corporation having an address at ▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇▇▇▇ ▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ (“AMGEN”), and ▇▇▇▇▇ NEUROSCIENCE, INC., a Delaware corporation having an address at ▇▇▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇ (“▇▇▇▇▇”). ▇▇▇▇▇ and AMGEN are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
Appears in 2 contracts
Sources: Exclusive License Agreement (Vigil Neuroscience, Inc.), Exclusive License Agreement (Vigil Neuroscience, Inc.)